RFOXN1 fusion protein
RFOXN1 fusion protein has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Feb 8, 2023: “Recombinant FOXN1 fusion protein increases T cell generation in aged mice”.
1 paper studies it2 findingsUpdated
None of its findings points the other way.
- 1 lab
- Funder: National Institute on Aging
- Animals1
What did studies of RFOXN1 fusion protein find?
2Studies of RFOXN1 fusion protein measured 2 outcomes; the most studied are peripheral T cells (1 study) and T cell generation (1).
Peripheral T cells
upin mice1
1 study
Peripheral T cells
upin mice1
RFOXN1 fusion protein increases peripheral T cells in mice.
“increased number of T cells in peripheral lymphoid organ”
Animalsaged micefusion protein containing the N-terminal of CCR9, FOXN1 and a protein transduction domain
Recombinant FOXN1 fusion protein increases T cell generation in aged mice
Research squarePreprint
T cell generation
upin mice1
1 study
T cell generation
upin mice1
RFOXN1 fusion protein increases T cell generation in mice.
“when injected intravenously into aged mice, the rFOXN1 fusion protein migrates into the thymus and enhances thymopoiesis, resulting in increased T cell generation in the thymus”
Animalsaged micefusion protein containing the N-terminal of CCR9, FOXN1 and a protein transduction domainthymus
Recombinant FOXN1 fusion protein increases T cell generation in aged mice
Research squarePreprint